Pedro Celso
Ruiz Artacho
Consultor Médico
David
Jiménez Castro
Publications dans lesquelles il/elle collabore avec David Jiménez Castro (58)
2024
-
Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry
Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152
-
Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis
Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537
-
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism
Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246
-
Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial
Chest, Vol. 165, Núm. 3, pp. 673-681
-
Predictors of pulmonary embolism in chronic obstructive pulmonary diseases patients admitted for worsening respiratory symptoms: An individual participant data meta-analyses
European Journal of Internal Medicine
-
Profilaxis de la enfermedad tromboembólica venosa en pacientes hospitalizados por patología médica desde los servicios de urgencias españoles: estudio PROTESU II
Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 36, Núm. 4, pp. 271-280
-
Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine
European Journal of Clinical Investigation
-
The prognostic value of blood cellular indices in pulmonary embolism
American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711
2023
2022
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347
-
Effect of Prognostic Guided Management of Patients With Acute Pulmonary Embolism According to the European Society of Cardiology Risk Stratification Model
Frontiers in Cardiovascular Medicine, Vol. 9
-
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4
-
Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism
Chest, Vol. 161, Núm. 2, pp. 524-534
-
Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism
Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 725-734
-
Multidisciplinary Consensus for the Management of Pulmonary Thromboembolism
Archivos de Bronconeumologia
-
Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry
Frontiers in Medicine, Vol. 9
-
Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism
The European respiratory journal, Vol. 59, Núm. 2
-
The hazard of combining anticoagulants with antiplatelets in patients with venous thromboembolism: Findings from the RIETE registry
Thrombosis Research
2021
-
Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis
Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 8, pp. 1981-1989
-
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism
European Respiratory Journal, Vol. 58, Núm. 1